Rituximab maintenance in follicular lymphoma.
Department of Medicine, University of Rochester Medical Center, Rochester, New York.
Paul M
PM
Barr
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy* / Q000401:mortality; D060046:Maintenance Chemotherapy; D058990:Molecular Targeted Therapy; D011379:Prognosis; D011788:Quality of Life; D000069283:Rituximab / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D000069283:Rituximab